MedPath

Drug Eluting Balloon vs conventional balloon predilatation an Open Randomized trial in Acute myocardial infarction.

Conditions
Acute Myocardial InfarctionPCIDrug eluting balloonstent
Registration Number
NL-OMON27108
Lead Sponsor
Maatschap Cardiologie Isala Klinieken
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
68
Inclusion Criteria

1. Males or females > 18 years of age and < 80 years with symptoms of AMI of more than 30 minutes but less than 24 hours

2. ST segment elevation of > 1 mV in 2 adjacent ECG leads, with cumulative ST segment deviation of 6 mm or more

Exclusion Criteria

- Women of child-bearing potential

1. Severe hepatic or renal disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary endpoint: <br /><br>- Late loss at 9 month follow-up by quantitative coronary angiography.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoint: <br /><br>Major adverse cardiac clinical events (death, re-infarction, target vessel revascularization) at 1, 9 and 12 months after treatment.
© Copyright 2025. All Rights Reserved by MedPath